MassMutual Private Wealth & Trust’s Travere Therapeutics TVTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9K	Buy	244 +9	+4%	+$399	﹤0.01%	1254
2026 Q1	$6.98K	Hold	235	–	–	﹤0.01%	1527
2025 Q4	$8.98K	Hold	235	–	–	﹤0.01%	1435
2025 Q3	$5.62K	Hold	235	–	–	﹤0.01%	1627
2025 Q2	$3.48K	Hold	235	–	–	﹤0.01%	1772
2025 Q1	$4.21K	Hold	235	–	–	﹤0.01%	1664
2024 Q4	$4.09K	Hold	235	–	–	﹤0.01%	1597
2024 Q3	$3.29K	Hold	235	–	–	﹤0.01%	1504
2024 Q2	$1.93K	Hold	235	–	–	﹤0.01%	1651
2024 Q1	$1.81K	Hold	235	–	–	﹤0.01%	1578
2023 Q4	$2.11K	Buy	+235	New	+$1.71K	﹤0.01%	1483

Other funds holding TVTX

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

MassMutual Private Wealth & Trust's TVTX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Travere Therapeutics (TVTX) stake by 3.8% in Q2 2026, buying an estimated $399 and bringing the position to 244 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

MassMutual Private Wealth & Trust first reported a position in TVTX in Q4 2023 and has held it in 11 quarters since. 62 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

MassMutual Private Wealth & Trust held 244 shares of Travere Therapeutics worth $13.9K as of Q2 2026.
MassMutual Private Wealth & Trust bought 9 Travere Therapeutics shares in Q2 2026, an estimated $399.
Travere Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1254 holding.
MassMutual Private Wealth & Trust first reported a position in Travere Therapeutics in Q4 2023 and has held it in 11 quarters since.
62 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.